Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial.
Petit A, Ducassou S, Leblanc T, Pasquet M, Rousseau A, Ragu C, Cachanado M, Nelken B, Bertrand Y, Michel G, Gandemer V, Cuccuini W, Fenneteau O, Lapillonne H, Auvrignon A, Baruchel A, Leverger G.
Petit A, et al. Among authors: auvrignon a.
Hemasphere. 2018 Nov 29;2(6):e159. doi: 10.1097/HS9.0000000000000159. eCollection 2018 Dec.
Hemasphere. 2018.
PMID: 31723797
Free PMC article.